| Literature DB >> 32344551 |
Nhan Trong Le1, Duc Viet Ho1, Tuan Quoc Doan1, Anh Tuan Le2, Ain Raal3, Donatella Usai4, Giuseppina Sanna5, Antonio Carta6, Paola Rappelli4, Nicia Diaz4, Piero Cappuccinelli4, Stefania Zanetti4, Hoai Thi Nguyen1, Matthew Gavino Donadu4,6.
Abstract
The present study aimed to determine the bioactivities of essential oils extracted from the leaves of Paramignya trimera and Limnocitrus littoralis, including cytotoxicity, antiviral, antibacterial, antimycotic, and antitrichomonas effects. Herein, it was indicated that P. trimera and L. littoralis oils showed no cytotoxicity on normal cells, namely MT-4, BHK-21, MDBK, and Vero-76. P. trimera oil (i) exhibited the strongest inhibition against Staphylococcus aureus with MIC and MLC values of 2% (v/v); (ii) showed MIC and MLC values of 8% (v/v) in Candida parapsilosis; and (iii) in the remaining strains, showed MIC and MLC values greater than or equal to 16% (v/v). On the other hand, L. littoralis oil (i) displayed the strongest inhibition against Candida tropicalis and Candida parapsilosis with 2% (v/v) of MIC and MLC; and (ii) in the remaining strains, possessed MIC and MLC greater than or equal to 16% (v/v). In addition, antitrichomonas activities of the oils were undertaken, showing IC50, IC90, MLC values, respectively, at 0.016%, 0.03%, and 0.06% (v/v) from P. trimera, and 0.03%, 0.06%, 0.12% (v/v) from L. littoralis, after 48 h of incubation. The oils were completely ineffective against ssRNA+ (HIV-1, YFV, BVDV, Sb-1, CV-B4), ssRNA- (RSV, VSV), dsRNA (Reo-1), and dsDNA (HSV-1, VV) viruses. This is the first report describing the cytotoxicity, antiviral, antibacterial, antimycotic, and antitrichomonas activities of the essential oils of P. trimera and L. littoralis.Entities:
Keywords: antibacterial activity; antifungal activity; essential oils; infections
Year: 2020 PMID: 32344551 PMCID: PMC7235712 DOI: 10.3390/antibiotics9040207
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Cytotoxicity and antiviral activity of essential oils from P. trimera and L. littoralis against representatives of ssRNA+ (HIV-1, YFV, BVDV, Sb-1, CV- B4), ssRNA− (RSV, VSV), dsRNA (Reo-1), and dsDNA (HSV-1, VV) viruses.
| Cell Lines and Virus | MT-4 | HIV-1IIIB | BHK-21 | YFV | Reo-1 | MDBK | BVDV | Vero-76 | RSV | VSV | HSV-1 | VV | Sb-1 | CV-B4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CC50 a | EC50 b | CC50 c | EC50 d | EC50 d | CC50 e | EC50 f | CC50 g | EC50 h | ||||||
| O.P.t | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
| O.L.l | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
| * Reference | ||||||||||||||
| RC1 | 40 | 0.003 ± 0.0003 | - | - | - | - | - | - | - | - | - | - | - | - |
| RC2 | - | - | 80 | 1.4 ± 0.2 | - | >100 | 1.7 ± 0.3 | - | - | - | - | - | - | - |
| RC3 | - | - | - | - | - | - | - | >100 | - | - | - | - | 2 | 2 ± 0.5 |
| RC4 | - | - | - | - | - | - | - | ≥14 | 2 ± 0.2 | - | - | - | - | - |
| RC5 | - | - | - | - | - | - | - | >100 | - | - | 3.0 ± 0.1 | - | - | - |
| RC6 | - | - | - | - | - | - | - | >100 | - | - | - | 1.7 ± 0.1 | - | - |
| RC7 | - | - | >100 | - | 17 | - | - | - | - | - | - | - | - | - |
Data represent mean values + standard deviation (SD) for three independent determinations. For values where SD is not shown, variation among duplicate samples was less than 15%. O.P.t: essential oil from the leaves of Paramignya trimera; O.L.l: essential oil from the leaves of Limnocitrus littoralis; RC1: Efavirenz; RC2: 2′-C-methylguanosine; RC3: Pleconaril; RC4: 6-aza-uridine; RC5: Acycloguanosine; RC6: Mycophenolic acid; RC7: 2′-C-methylcytidine. a Compound concentration (µg/mL) required to reduce the proliferation of mock-infected MT-4 cells by 50%, as determined by the 3-(4,5-dimethylthiazol-1-yl)-2,5-diphenyltetrazolium bromide (MTT) method. b Compound concentration (µg/mL) required to achieve 50% protection of MT-4 cells from HIV-1-induced cytopathogenicity, as determined by the MTT method. c Compound concentration (µg/mL) required to reduce the viability of mock-infected Baby Hamster Kidney (BHK) cells by 50%, as determined by the MTT method. d Compound concentration (µg/mL) required to achieve 50% protection of BHK cells from yellow fever virus (YFV) or Reo-1 induced cytopathogenicity, as determined by the MTT method. e Compound concentration (µg/mL) required to reduce the viability of mock-infected Madin Darby Bovine Kidney (MDBK) cells by 50%, as determined by the MTT method. f Compound concentration (µg/mL) required to achieve 50% protection of MDBK cells from bovine viral diarrhoea virus (BVDV)-induced cytopathogenicity, as determined by the MTT method. g Compound concentration (µg/mL) required to reduce the viability of mock-infected Vero-76 cells by 50%, as determined by the MTT method. h Compound concentration (µg/mL) required to reduce the plaque number of RSV, VSV, HSV-1, VV, Sb-1, and CV-B4 by 50% in Vero-76 monolayers. * Reference compound: CC50 and EC50 are in µM.
Antimicrobial activities (MIC and MLC) of essential oils from the leaves of P. trimera and L. littoralis.
| Strains | ||||
|---|---|---|---|---|
| MIC (% | MLC (% | MIC (% | MLC (% | |
|
| ||||
| 2 ± 0.5 | 2 ± 0.5 | >16 ± 0.5 | >16 ± 0.5 | |
| 2 ± 0.5 | 2 ± 0.5 | >16 ± 0.5 | >16 ± 1 | |
| 16 ± 0.5 | 16 ± 1 | >16 ± 1 | >16 ± 1 | |
|
| ||||
| >16 ± 1 | >16 ± 1 | >16 ± 1 | >16 ± 0.5 | |
| >16 ± 1 | >16 ± 0.5 | >16 ± 0.5 | >16 ± 0.5 | |
| 16 ± 0.5 | >16 ± 1 | >16 ± 1 | >16 ± 1 | |
| 16 ± 0.5 | >16 ± 0.5 | >16 ± 0.5 | >16 ± 1 | |
| >16 ± 0.5 | >16 ± 0.5 | >16 ± 0.5 | >16 ± 1 | |
|
| ||||
| 16 ± 1 | 16 ± 0.5 | 16 ± 0.5 | 16 ± 1 | |
| 16 ± 1.5 | 16 ± 1 | >16 ± 0.5 | >16 ± 0.5 | |
| 16 ± 0.5 | 16 ± 1 | 2 ± 0.5 | 2 ± 0.5 | |
| 8 ± 0.5 | 8 ± 0.5 | 2 ± 0.5 | 2 ± 0.5 | |
MIC and MLC values represent the mean ± SD of three independent experiments. MIC: Minimum Inhibitory Concentrations. MLC: Minimum Lethal Concentrations.
In vitro anti-T. vaginalis activity of essential oils from the leaves of P. trimera and L. littoralis.
| Time | ||||||
|---|---|---|---|---|---|---|
| IC50 | IC90 | MLC | IC50 | IC90 | MLC | |
|
| 2 | 4 | 8 | 2 | 8 | 16 |
|
| 0.5 | 1 | 2 | 1 | 4 | 8 |
|
| 0.03 | 0.06 | 0.12 | 0.12 | 0.25 | 0.5 |
|
| 0.016 | 0.03 | 0.06 | 0.03 | 0.06 | 0.12 |
Data represent mean values for two independent experiments. IC50: The concentration that causes 50% Trichomonas growth inhibition (% v/v). IC90: The concentration that causes ≥ 90% Trichomonas growth inhibition (% v/v). MLC: The concentration that causes the death of 100% Trichomonas (% v/v).